Vitibiotech ApS

CVR45127044
Company financials

Key figures

Updated 30 Jun 2026
Return on assets
-196.8%
Return on equity
–
Current ratio
1,446.4%
Equity ratio
-132.9%

Profit and loss

Reporting period
Gross profit
-583,618
Operating profit
-1,390,821
Finance income
1,712
Finance expenses
96,633
Tax expense
-166,915
Profit/loss for the year
-1,318,827

Employees

Reporting period
Avg. employees
1
Personnel costs
807,203 DKK

Balance sheet

Reporting period
Cash and cash equivalents
501,171
Current assets
706,655
Total assets
706,655
Equity
-938,827
Liabilities
1,645,482
Current liabilities
48,855

Working capital

Reporting period
Other current receivables
38,569
Trade payables
6,575

Capital and dividend

Reporting period
Contributed capital
380,000
Retained earnings
-1,318,827

Annual report highlights

Official annual report · 2025

Business and development

Primary activities

Vitibiotech's ambition is to develop, produce, and eventually sell bacteria-based solutions for combating mold fungi in fruits and berries, with a particular focus on grapevines and grapes. The focus in 2025 has been on establishing the company and developing solutions.

Development in activities and financial affairs

The income statement of the Company for 2024/25 shows a loss of DKK 1,318,827, and at 31 December 2025 the balance sheet of the Company shows a negative equity of DKK 938,827.

Risks and material matters

Going-concern uncertainty

The Company has for the financial year a negative result of DKK 1,319 thousand and has cash and cash equivalents of DKK 501 thousand and an equity of DKK -939 thousand as of 31 December 2025.Based on the cash position and credit facility at year-end, and the latest approved budget, the Company has a run rate until minimum October 2027.Accordingly, it is Management's assessment that there is no material uncertainty related to going concern.

Unusual matters affecting recognition or measurement

The financial position at 31 December 2025 of the Company and the results of the activities and cash flows of the Company for the financial year for 2024/25 have not been affected by any unusual events.

Significant events after the reporting period

No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.

Commitments and security

Contingent liabilities

The Company has entered into lease agreements with a 3-month notice period, with commitment 31 December 2025 amounting to DKK 76 thousand (regarding lease in Copenhagen, Denmark).Other than this, the Company has not entered into any mutually binding agreements as of the balance sheet date that affect the Company's financial position.